CLINICAL TRIALS PROFILE FOR LIVMARLI
✉ Email this page to a colleague
All Clinical Trials for LIVMARLI
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT07290257 ↗ | Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli in Patients With Alagille Syndrome in the European Union (LEAP-EU) | RECRUITING | Mirum Pharmaceuticals, Inc. | PHASE4 | 2025-09-25 | The key objectives of this low-intervention clinical study are to evaluate tolerability, long-term safety and long-term efficacy for patients with Alagille syndrome (ALGS) who are prescribed Livmarli. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LIVMARLI
Condition Name
Clinical Trial Locations for LIVMARLI
Clinical Trial Progress for LIVMARLI
Clinical Trial Phase
Clinical Trial Sponsors for LIVMARLI
Sponsor Name
